Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cullinan Therapeutics Inc (CGEM)

Cullinan Therapeutics Inc (CGEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cullinan Therapeutics Inc ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 USA

www.cullinanoncology.com Employees: 111 P: 617-410-4650

Sector:

Medical

Description:

Cullinan Therapeutics Inc. is a biopharmaceutical company focused on developing modality-agnostic targeted therapies. The company's product pipeline consists CLN-978. Cullinan Therapeutics Inc., formerly known as Cullinan Oncology Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 633,295
Enterprise Value, $K 550,285
Shares Outstanding, K 59,076
Float, K 54,846
% Float 92.84%
Short Interest, K 8,136
Short Float 13.77%
Days to Cover 7.73
Short Volume Ratio 0.44
% of Insider Shareholders 7.16%
% of Institutional Shareholders 86.31%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -167,380 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -50,610 K
EBIT, $ -241,450 K
EBITDA, $ -241,140 K

Growth:

1-Year Return 5.95%
3-Year Return 0.75%
5-Year Return -72.16%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.77 on 11/06/25
Next Earnings Date 02/26/26
Earnings Per Share ttm -3.31
EPS Growth vs. Prev Qtr 28.04%
EPS Growth vs. Prev Year -11.59%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CGEM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.58%
Return-on-Assets % -39.31%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.40
Book Value/Share 7.64
Interest Coverage -2.10
60-Month Beta -0.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar